Latest News & Features
Europe
A German Federal Court decision has given patent applicants in the life sciences field plenty to think about,
as Wolfgang Bublak and Axel Berger explain. 16 October 2013
Asia
Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court. 15 October 2013
Americas
After 39 years at the firm, IP litigator Trevor Cook will be leaving UK-based Bird & Bird LLP to join Wilmer Cutler Pickering Hale and Dorr LLP in New York. 15 October 2013
Americas
US biotech company Myriad Genetics is facing claims that 14 of its patents covering tests for breast and ovarian cancer are invalid and non-infringed by Quest Diagnostics. 14 October 2013
Americas
Dow Chemical Company subsidiary Dow AgroSciences has won another lawsuit involving its Enlist weed control technology. 10 October 2013
Americas
Andrulis Pharmaceuticals Corp has accused Celgene Corp of infringing and inducing the infringement of one of its patents related to a method of treating cancer. 8 October 2013
Americas
Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit. 8 October 2013
Europe
Teva Pharmaceutical Industries has claimed victory in a patent revocation action brought by generic drug maker Mylan in the Hague over its blockbuster Copaxone drug, used in the treatment of multiple sclerosis. 4 October 2013
article
Swedish law firm Vinge has hired IP specialist Ulf Dahlgren to its Stockholm office from rivals Lindahl, following Håkan Borgenhäll’s move from the same firm in April. 3 October 2013
Americas
Mylan Inc will be forced to divest injectable generic drugs before it can complete a proposed $1.85 billion acquisition of Agila Specialities Global Pte Ltd and Agila Specialties Pvt Ltd after the FTC applied conditions to the deal. 2 October 2013